Southland Equity Partners LLC Purchases 1,523 Shares of CVS Health Co. (NYSE:CVS)

Southland Equity Partners LLC raised its holdings in CVS Health Co. (NYSE:CVS) by 44.0% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,985 shares of the pharmacy operator’s stock after acquiring an additional 1,523 shares during the period. Southland Equity Partners LLC’s holdings in CVS Health were worth $224,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Secure Asset Management LLC increased its stake in CVS Health by 13.8% in the fourth quarter. Secure Asset Management LLC now owns 33,271 shares of the pharmacy operator’s stock valued at $1,494,000 after acquiring an additional 4,024 shares during the last quarter. Donoghue Forlines LLC purchased a new position in shares of CVS Health during the 4th quarter valued at about $1,400,000. SG Americas Securities LLC lifted its position in CVS Health by 47.2% in the 4th quarter. SG Americas Securities LLC now owns 28,801 shares of the pharmacy operator’s stock worth $1,293,000 after buying an additional 9,234 shares during the last quarter. Perfromance Wealth Partners LLC purchased a new stake in CVS Health in the fourth quarter worth approximately $475,000. Finally, Fort Washington Investment Advisors Inc. OH raised its stake in shares of CVS Health by 17.6% during the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 1,089,654 shares of the pharmacy operator’s stock worth $48,915,000 after acquiring an additional 163,148 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

CVS Health Stock Up 1.6 %

CVS stock opened at $54.71 on Friday. CVS Health Co. has a fifty-two week low of $43.56 and a fifty-two week high of $80.75. The company has a market capitalization of $68.84 billion, a price-to-earnings ratio of 13.88, a price-to-earnings-growth ratio of 0.80 and a beta of 0.59. The business’s 50 day moving average price is $51.21 and its two-hundred day moving average price is $56.22. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. During the same quarter in the prior year, the company earned $2.21 earnings per share. The firm’s quarterly revenue was up 6.3% compared to the same quarter last year. As a group, analysts forecast that CVS Health Co. will post 5.22 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.86%. The ex-dividend date is Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.

Wall Street Analysts Forecast Growth

CVS has been the topic of several recent research reports. Evercore ISI increased their target price on shares of CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a report on Tuesday, October 8th. StockNews.com downgraded CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. TD Cowen increased their target price on CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a report on Monday, November 25th. Piper Sandler decreased their price target on CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research note on Monday, November 25th. Finally, UBS Group increased their price objective on CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a research note on Thursday, November 7th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat.com, CVS Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $68.71.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.